imipenem, anhydrous has been researched along with Tracheitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brunin, G; Decamps, F; Dewavrin, F; Di Pompeo, C; Durocher, A; Favory, R; Jozefowicz, E; Mathieu, D; Nseir, S | 1 |
| Hirai, K; Honda, T; Yamazaki, Y | 1 |
1 trial(s) available for imipenem, anhydrous and Tracheitis
| Article | Year |
|---|---|
Antimicrobial treatment for ventilator-associated tracheobronchitis: a randomized, controlled, multicenter study.
Topics: Aged; Aminoglycosides; Anti-Bacterial Agents; Bronchitis; Female; Hospital Mortality; Humans; Imipenem; Intensive Care Units; Male; Middle Aged; Pneumonia, Ventilator-Associated; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Respiration, Artificial; Time Factors; Tracheitis | 2008 |
1 other study(ies) available for imipenem, anhydrous and Tracheitis
| Article | Year |
|---|---|
Pseudomembranous tracheobronchitis caused by methicillin-resistant Staphylococcus aureus.
Topics: Aged; Anti-Bacterial Agents; Bronchi; Bronchitis; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Humans; Imipenem; Influenza, Human; Male; Methicillin; Methicillin Resistance; Respiratory Distress Syndrome; Staphylococcal Infections; Staphylococcus aureus; Trachea; Tracheitis; Vancomycin | 2002 |